Abstract

BackgroundThe recent marketing of new high-cost antifungal agents (echinocandins and azoles) requires the design of cost-effective treatment protocols.Purpose A new treatment guide for candidaemia and other invasive fungal infections for...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group
Shun-Ichi Kimura ... Kazuo Tamura
Blood | VOL. 132
Shun-Ichi Kimura, et. al.Shun-Ichi Kimura ... Kazuo Tamura
29 Nov 2018
Analysis of Efficacy, Safety and Costs of Systemic Antifungal Agents in 159 Consecutive High-Risk Cancer Patients for the Establishment of Standardized Guidelines
Werner Neubauer ... Monika Engelhardt
Blood | VOL. 112
Werner Neubauer, et. al.Werner Neubauer ... Monika Engelhardt
16 Nov 2008
Systemic Antifungal Drugs in the Hematology and Oncology Setting: A Real-Life Analysis in Consecutive Leukemia Patients of Patterns of Usage and Associated Problems,
Barbara Metzke ... Monika Engelhardt
Blood | VOL. 118
Barbara Metzke, et. al.Barbara Metzke ... Monika Engelhardt
18 Nov 2011
Risk-Adapted Anti-Mould Prophylaxis Improves Supportive Care in Childhood Leukemia Patients
Roman Crazzolara ... Gabriele Kropshofer
Blood | VOL. 132
Roman Crazzolara, et. al.Roman Crazzolara ... Gabriele Kropshofer
29 Nov 2018
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
EAHP and GS1 publish report of UZ Leuven meeting on bedside scanning and medicines bar coding
Richard Price
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Richard PriceRichard Price
19 May 2014
In peer review we trust—or do we?
Phil Wiffen
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil WiffenPhil Wiffen
19 May 2014
European Parliament Committee approves €3 billion public-private partnership with industry on new medicine development
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
19 May 2014
Chapter 5: Appraising the evidence
Phil Wiffen ... Hao Lu
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil Wiffen, et. al.Phil Wiffen ... Hao Lu
19 May 2014
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.